Status:
COMPLETED
An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder
Lead Sponsor:
AstraZeneca
Conditions:
Bipolar Disorder
Eligibility:
All Genders
Brief Summary
The aim of this study is to describe the treatment pattern and patient characteristics in real life setting in patients with Bipolar disorder treated with Seroquel XR and/or Seroquel IR in Sweden.
Detailed Description
An epidemiological registry study to evaluate clinical practice treatment in patients with Bipolar Disorder treated with quetiapine XR and/or quetiapine IR
Eligibility Criteria
Inclusion
- Patients with a diagnosis of BD.
Exclusion
- Patients with a diagnosis of any schizophrenia spectrum disorder after the diagnosis of bipolar disorder.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
16000 Patients enrolled
Trial Details
Trial ID
NCT01455961
Start Date
November 1 2011
End Date
April 1 2012
Last Update
August 21 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.